Global Bile Duct Cancer Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: G56CFFFFA491EN
QYResearch

Abstracts

This report focuses on the global Bile Duct Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bile Duct Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• F. Hoffmann-La Roche
• Bristol-Myers Squibb
• Teva Pharmaceutical
• Eli Lilly and Company
• Sanofi
• Fresenius Kabi
• Mylan

Market segment by Type, the product can be split into

• 5-fluorouracil
• Gemcitabine
• Cisplatin
• Other

Market segment by Application, split into

• Hospitals & Clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Bile Duct Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Bile Duct Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bile Duct Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bile Duct Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bile Duct Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 5-fluorouracil
  1.4.3 Gemcitabine
  1.4.4 Cisplatin
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Bile Duct Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinics
  1.5.3 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bile Duct Cancer Market Perspective (2015-2026)
2.2 Bile Duct Cancer Growth Trends by Regions
  2.2.1 Bile Duct Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bile Duct Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Bile Duct Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bile Duct Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Bile Duct Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bile Duct Cancer Players by Market Size
  3.1.1 Global Top Bile Duct Cancer Players by Revenue (2015-2020)
  3.1.2 Global Bile Duct Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bile Duct Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bile Duct Cancer Market Concentration Ratio
  3.2.1 Global Bile Duct Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Revenue in 2019
3.3 Bile Duct Cancer Key Players Head office and Area Served
3.4 Key Players Bile Duct Cancer Product Solution and Service
3.5 Date of Enter into Bile Duct Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bile Duct Cancer Historic Market Size by Type (2015-2020)
4.2 Global Bile Duct Cancer Forecasted Market Size by Type (2021-2026)

5 BILE DUCT CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bile Duct Cancer Market Size by Application (2015-2020)
5.2 Global Bile Duct Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bile Duct Cancer Market Size (2015-2020)
6.2 Bile Duct Cancer Key Players in North America (2019-2020)
6.3 North America Bile Duct Cancer Market Size by Type (2015-2020)
6.4 North America Bile Duct Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bile Duct Cancer Market Size (2015-2020)
7.2 Bile Duct Cancer Key Players in Europe (2019-2020)
7.3 Europe Bile Duct Cancer Market Size by Type (2015-2020)
7.4 Europe Bile Duct Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Bile Duct Cancer Market Size (2015-2020)
8.2 Bile Duct Cancer Key Players in China (2019-2020)
8.3 China Bile Duct Cancer Market Size by Type (2015-2020)
8.4 China Bile Duct Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Bile Duct Cancer Market Size (2015-2020)
9.2 Bile Duct Cancer Key Players in Japan (2019-2020)
9.3 Japan Bile Duct Cancer Market Size by Type (2015-2020)
9.4 Japan Bile Duct Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Bile Duct Cancer Market Size (2015-2020)
10.2 Bile Duct Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bile Duct Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Bile Duct Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Bile Duct Cancer Market Size (2015-2020)
11.2 Bile Duct Cancer Key Players in India (2019-2020)
11.3 India Bile Duct Cancer Market Size by Type (2015-2020)
11.4 India Bile Duct Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Bile Duct Cancer Market Size (2015-2020)
12.2 Bile Duct Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Bile Duct Cancer Market Size by Type (2015-2020)
12.4 Central & South America Bile Duct Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Bile Duct Cancer Introduction
  13.1.4 Pfizer Revenue in Bile Duct Cancer Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 F. Hoffmann-La Roche
  13.2.1 F. Hoffmann-La Roche Company Details
  13.2.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.2.3 F. Hoffmann-La Roche Bile Duct Cancer Introduction
  13.2.4 F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2015-2020)
  13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Bristol-Myers Squibb
  13.3.1 Bristol-Myers Squibb Company Details
  13.3.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.3.3 Bristol-Myers Squibb Bile Duct Cancer Introduction
  13.3.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2015-2020)
  13.3.5 Bristol-Myers Squibb Recent Development
13.4 Teva Pharmaceutical
  13.4.1 Teva Pharmaceutical Company Details
  13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.4.3 Teva Pharmaceutical Bile Duct Cancer Introduction
  13.4.4 Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2015-2020)
  13.4.5 Teva Pharmaceutical Recent Development
13.5 Eli Lilly and Company
  13.5.1 Eli Lilly and Company Company Details
  13.5.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.5.3 Eli Lilly and Company Bile Duct Cancer Introduction
  13.5.4 Eli Lilly and Company Revenue in Bile Duct Cancer Business (2015-2020)
  13.5.5 Eli Lilly and Company Recent Development
13.6 Sanofi
  13.6.1 Sanofi Company Details
  13.6.2 Sanofi Business Overview and Its Total Revenue
  13.6.3 Sanofi Bile Duct Cancer Introduction
  13.6.4 Sanofi Revenue in Bile Duct Cancer Business (2015-2020)
  13.6.5 Sanofi Recent Development
13.7 Fresenius Kabi
  13.7.1 Fresenius Kabi Company Details
  13.7.2 Fresenius Kabi Business Overview and Its Total Revenue
  13.7.3 Fresenius Kabi Bile Duct Cancer Introduction
  13.7.4 Fresenius Kabi Revenue in Bile Duct Cancer Business (2015-2020)
  13.7.5 Fresenius Kabi Recent Development
13.8 Mylan
  13.8.1 Mylan Company Details
  13.8.2 Mylan Business Overview and Its Total Revenue
  13.8.3 Mylan Bile Duct Cancer Introduction
  13.8.4 Mylan Revenue in Bile Duct Cancer Business (2015-2020)
  13.8.5 Mylan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bile Duct Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Bile Duct Cancer Revenue
Table 3. Ranking of Global Top Bile Duct Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bile Duct Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 5-fluorouracil
Table 6. Key Players of Gemcitabine
Table 7. Key Players of Cisplatin
Table 8. Key Players of Other
Table 9. Global Bile Duct Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Bile Duct Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Bile Duct Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Bile Duct Cancer Market Share by Regions (2015-2020)
Table 13. Global Bile Duct Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Bile Duct Cancer Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Bile Duct Cancer Market Growth Strategy
Table 19. Main Points Interviewed from Key Bile Duct Cancer Players
Table 20. Global Bile Duct Cancer Revenue by Players (2015-2020) (Million US$)
Table 21. Global Bile Duct Cancer Market Share by Players (2015-2020)
Table 22. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer as of 2019)
Table 23. Global Bile Duct Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Bile Duct Cancer Product Solution and Service
Table 26. Date of Enter into Bile Duct Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 29. Global Bile Duct Cancer Market Size Share by Type (2015-2020)
Table 30. Global Bile Duct Cancer Revenue Market Share by Type (2021-2026)
Table 31. Global Bile Duct Cancer Market Size Share by Application (2015-2020)
Table 32. Global Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 33. Global Bile Duct Cancer Market Size Share by Application (2021-2026)
Table 34. North America Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Bile Duct Cancer Market Share (2019-2020)
Table 36. North America Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 37. North America Bile Duct Cancer Market Share by Type (2015-2020)
Table 38. North America Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 39. North America Bile Duct Cancer Market Share by Application (2015-2020)
Table 40. Europe Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Bile Duct Cancer Market Share (2019-2020)
Table 42. Europe Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Bile Duct Cancer Market Share by Type (2015-2020)
Table 44. Europe Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Bile Duct Cancer Market Share by Application (2015-2020)
Table 46. China Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 47. China Key Players Bile Duct Cancer Market Share (2019-2020)
Table 48. China Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 49. China Bile Duct Cancer Market Share by Type (2015-2020)
Table 50. China Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 51. China Bile Duct Cancer Market Share by Application (2015-2020)
Table 52. Japan Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Bile Duct Cancer Market Share (2019-2020)
Table 54. Japan Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Bile Duct Cancer Market Share by Type (2015-2020)
Table 56. Japan Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Bile Duct Cancer Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Bile Duct Cancer Market Share (2019-2020)
Table 60. Southeast Asia Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Bile Duct Cancer Market Share by Type (2015-2020)
Table 62. Southeast Asia Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Bile Duct Cancer Market Share by Application (2015-2020)
Table 64. India Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 65. India Key Players Bile Duct Cancer Market Share (2019-2020)
Table 66. India Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 67. India Bile Duct Cancer Market Share by Type (2015-2020)
Table 68. India Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 69. India Bile Duct Cancer Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Bile Duct Cancer Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Bile Duct Cancer Market Share (2019-2020)
Table 72. Central & South America Bile Duct Cancer Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Bile Duct Cancer Market Share by Type (2015-2020)
Table 74. Central & South America Bile Duct Cancer Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Bile Duct Cancer Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Product
Table 84. F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Product
Table 89. Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Teva Pharmaceutical Company Details
Table 92. Teva Pharmaceutical Business Overview
Table 93. Teva Pharmaceutical Product
Table 94. Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 95. Teva Pharmaceutical Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Product
Table 99. Eli Lilly and Company Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 100. Eli Lilly and Company Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. Fresenius Kabi Company Details
Table 107. Fresenius Kabi Business Overview
Table 108. Fresenius Kabi Product
Table 109. Fresenius Kabi Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 110. Fresenius Kabi Recent Development
Table 111. Mylan Business Overview
Table 112. Mylan Product
Table 113. Mylan Company Details
Table 114. Mylan Revenue in Bile Duct Cancer Business (2015-2020) (Million US$)
Table 115. Mylan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bile Duct Cancer Market Share by Type: 2020 VS 2026
Figure 2. 5-fluorouracil Features
Figure 3. Gemcitabine Features
Figure 4. Cisplatin Features
Figure 5. Other Features
Figure 6. Global Bile Duct Cancer Market Share by Application: 2020 VS 2026
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Bile Duct Cancer Report Years Considered
Figure 10. Global Bile Duct Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Bile Duct Cancer Market Share by Regions: 2020 VS 2026
Figure 12. Global Bile Duct Cancer Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Bile Duct Cancer Market Share by Players in 2019
Figure 15. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bile Duct Cancer as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Bile Duct Cancer Revenue in 2019
Figure 17. North America Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Bile Duct Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 26. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. F. Hoffmann-La Roche Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 28. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 30. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Teva Pharmaceutical Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 32. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 34. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Sanofi Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 36. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 38. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Mylan Revenue Growth Rate in Bile Duct Cancer Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed